Decoy Therapeutics exploring pan-filovirus program via FDA Animal Rule pathway and non-dilutive funding

Decoy Therapeutics is pursuing a pan-filovirus program through the FDA Animal Rule pathway, with the company also exploring non-dilutive funding to support it.

Detected & updated continuously · Source: Nebula